Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart
Daunorubicin (DNR) and doxorubicin (DOX) are two of the most effective anthracycline drugs known for the treatment of systemic neoplasms and solid tumors. However, their clinical use is hampered due to profound cardiotoxicity. The mechanism by which DNR injures the heart remains to be fully elucidat...
Gespeichert in:
| Veröffentlicht in: | Experimental biology and medicine (Maywood, N.J.) N.J.), 2012-02, Vol.237 (2), p.219-226 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 226 |
|---|---|
| container_issue | 2 |
| container_start_page | 219 |
| container_title | Experimental biology and medicine (Maywood, N.J.) |
| container_volume | 237 |
| creator | Sishi, Balindiwe J N Bester, Dirk J Wergeland, Anita Loos, Benjamin Jonassen, Anne K van Rooyen, Jacques Engelbrecht, Anna-Mart |
| description | Daunorubicin (DNR) and doxorubicin (DOX) are two of the most effective anthracycline drugs known for the treatment of systemic neoplasms and solid tumors. However, their clinical use is hampered due to profound cardiotoxicity. The mechanism by which DNR injures the heart remains to be fully elucidated. Recent reports have indicated that DOX activates ubiquitin proteasome-mediated degradation of specific transcription factors; however, no reports exist on the effect of DNR on the E3 ubiquitin ligases, MURF-1 (muscle ring finger 1) and MAFbx (muscle atrophy F-box). The aim of this study was to investigate the effect of DNR treatment on the protein and organelle degradation systems in the heart and to elucidate some of the signalling mechanisms involved. Adult rats were divided into two groups where one group received six intraperitoneal injections of 2 mg/kg DNR on alternate days and the other group received saline injections as control. Hearts were excised and perfused on a working heart system the day after the last injection and freeze-clamped for biochemical analysis. DNR treatment significantly attenuated cardiac function and increased apoptosis in the heart. DNR-induced cardiac cytotoxicity was associated with upregulation of the E3 ligases, MURF-1 and MAFbx and also caused significant increases in two markers of autophagy, beclin-1 and LC3. These changes observed in the heart were also associated with attenuation of the phosphoinositide 3-kinase/Akt signalling pathway. |
| doi_str_mv | 10.1258/ebm.2011.011106 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_923189505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1258_ebm.2011.011106</sage_id><sourcerecordid>923189505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-4d7566c35d929852a3d7d3130276b45d7376a0a1fbfa90b6961898c2d4899eed3</originalsourceid><addsrcrecordid>eNp1kDtPwzAURi0EoqUwsyFvLKT1I3biEUF5SJVYYGCynNhpXeVVOxbqv8dVWjaGq3uH833SPQDcYjTHhOULUzRzgjCex8GIn4EpZpQllAtxfrozRCbgyvstQphlhF-CCSGU5EykU_D9rELbuVDY0rZw2Bin-j20Hirvu9KqwWj4Y4cNDL0z61CrwXYt7Cq4pDCGdsEOMVfbtfLGw7ECboxywzW4qFTtzc1xz8DXy_Lz6S1Zfby-Pz2ukpJSOiSpzhjnJWVaEJEzoqjONMUUkYwXKdMZzbhCCldFpQQquOA4F3lJdJoLYYymM3A_9vau2wXjB9lYX5q6Vq3pgpeC0JhgiEVyMZKl67x3ppK9s41ye4mRPOiUUac86JSjzpi4O3aHojH6jz_5i8DDCHi1NnLbBdfGX__t-wVIDH4l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>923189505</pqid></control><display><type>article</type><title>Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Sishi, Balindiwe J N ; Bester, Dirk J ; Wergeland, Anita ; Loos, Benjamin ; Jonassen, Anne K ; van Rooyen, Jacques ; Engelbrecht, Anna-Mart</creator><creatorcontrib>Sishi, Balindiwe J N ; Bester, Dirk J ; Wergeland, Anita ; Loos, Benjamin ; Jonassen, Anne K ; van Rooyen, Jacques ; Engelbrecht, Anna-Mart</creatorcontrib><description>Daunorubicin (DNR) and doxorubicin (DOX) are two of the most effective anthracycline drugs known for the treatment of systemic neoplasms and solid tumors. However, their clinical use is hampered due to profound cardiotoxicity. The mechanism by which DNR injures the heart remains to be fully elucidated. Recent reports have indicated that DOX activates ubiquitin proteasome-mediated degradation of specific transcription factors; however, no reports exist on the effect of DNR on the E3 ubiquitin ligases, MURF-1 (muscle ring finger 1) and MAFbx (muscle atrophy F-box). The aim of this study was to investigate the effect of DNR treatment on the protein and organelle degradation systems in the heart and to elucidate some of the signalling mechanisms involved. Adult rats were divided into two groups where one group received six intraperitoneal injections of 2 mg/kg DNR on alternate days and the other group received saline injections as control. Hearts were excised and perfused on a working heart system the day after the last injection and freeze-clamped for biochemical analysis. DNR treatment significantly attenuated cardiac function and increased apoptosis in the heart. DNR-induced cardiac cytotoxicity was associated with upregulation of the E3 ligases, MURF-1 and MAFbx and also caused significant increases in two markers of autophagy, beclin-1 and LC3. These changes observed in the heart were also associated with attenuation of the phosphoinositide 3-kinase/Akt signalling pathway.</description><identifier>ISSN: 1535-3702</identifier><identifier>EISSN: 1535-3699</identifier><identifier>DOI: 10.1258/ebm.2011.011106</identifier><identifier>PMID: 22328594</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Animals ; Antibiotics, Antineoplastic - pharmacology ; Apoptosis ; Apoptosis Regulatory Proteins - biosynthesis ; Beclin-1 ; Caspase 3 - metabolism ; Daunorubicin - pharmacology ; Gene Expression Regulation, Enzymologic ; Male ; Microtubule-Associated Proteins - biosynthesis ; Muscle Proteins - metabolism ; Myocardium - enzymology ; Phosphatidylinositol 3-Kinases - metabolism ; Proteasome Endopeptidase Complex - metabolism ; Rats ; Rats, Wistar ; Signal Transduction ; SKP Cullin F-Box Protein Ligases - metabolism ; Tripartite Motif Proteins ; Ubiquitin - metabolism ; Ubiquitin-Protein Ligases - metabolism</subject><ispartof>Experimental biology and medicine (Maywood, N.J.), 2012-02, Vol.237 (2), p.219-226</ispartof><rights>2012 by the Society for Experimental Biology and Medicine</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-4d7566c35d929852a3d7d3130276b45d7376a0a1fbfa90b6961898c2d4899eed3</citedby><cites>FETCH-LOGICAL-c333t-4d7566c35d929852a3d7d3130276b45d7376a0a1fbfa90b6961898c2d4899eed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22328594$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sishi, Balindiwe J N</creatorcontrib><creatorcontrib>Bester, Dirk J</creatorcontrib><creatorcontrib>Wergeland, Anita</creatorcontrib><creatorcontrib>Loos, Benjamin</creatorcontrib><creatorcontrib>Jonassen, Anne K</creatorcontrib><creatorcontrib>van Rooyen, Jacques</creatorcontrib><creatorcontrib>Engelbrecht, Anna-Mart</creatorcontrib><title>Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart</title><title>Experimental biology and medicine (Maywood, N.J.)</title><addtitle>Exp Biol Med (Maywood)</addtitle><description>Daunorubicin (DNR) and doxorubicin (DOX) are two of the most effective anthracycline drugs known for the treatment of systemic neoplasms and solid tumors. However, their clinical use is hampered due to profound cardiotoxicity. The mechanism by which DNR injures the heart remains to be fully elucidated. Recent reports have indicated that DOX activates ubiquitin proteasome-mediated degradation of specific transcription factors; however, no reports exist on the effect of DNR on the E3 ubiquitin ligases, MURF-1 (muscle ring finger 1) and MAFbx (muscle atrophy F-box). The aim of this study was to investigate the effect of DNR treatment on the protein and organelle degradation systems in the heart and to elucidate some of the signalling mechanisms involved. Adult rats were divided into two groups where one group received six intraperitoneal injections of 2 mg/kg DNR on alternate days and the other group received saline injections as control. Hearts were excised and perfused on a working heart system the day after the last injection and freeze-clamped for biochemical analysis. DNR treatment significantly attenuated cardiac function and increased apoptosis in the heart. DNR-induced cardiac cytotoxicity was associated with upregulation of the E3 ligases, MURF-1 and MAFbx and also caused significant increases in two markers of autophagy, beclin-1 and LC3. These changes observed in the heart were also associated with attenuation of the phosphoinositide 3-kinase/Akt signalling pathway.</description><subject>Animals</subject><subject>Antibiotics, Antineoplastic - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis Regulatory Proteins - biosynthesis</subject><subject>Beclin-1</subject><subject>Caspase 3 - metabolism</subject><subject>Daunorubicin - pharmacology</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Male</subject><subject>Microtubule-Associated Proteins - biosynthesis</subject><subject>Muscle Proteins - metabolism</subject><subject>Myocardium - enzymology</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Proteasome Endopeptidase Complex - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Signal Transduction</subject><subject>SKP Cullin F-Box Protein Ligases - metabolism</subject><subject>Tripartite Motif Proteins</subject><subject>Ubiquitin - metabolism</subject><subject>Ubiquitin-Protein Ligases - metabolism</subject><issn>1535-3702</issn><issn>1535-3699</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kDtPwzAURi0EoqUwsyFvLKT1I3biEUF5SJVYYGCynNhpXeVVOxbqv8dVWjaGq3uH833SPQDcYjTHhOULUzRzgjCex8GIn4EpZpQllAtxfrozRCbgyvstQphlhF-CCSGU5EykU_D9rELbuVDY0rZw2Bin-j20Hirvu9KqwWj4Y4cNDL0z61CrwXYt7Cq4pDCGdsEOMVfbtfLGw7ECboxywzW4qFTtzc1xz8DXy_Lz6S1Zfby-Pz2ukpJSOiSpzhjnJWVaEJEzoqjONMUUkYwXKdMZzbhCCldFpQQquOA4F3lJdJoLYYymM3A_9vau2wXjB9lYX5q6Vq3pgpeC0JhgiEVyMZKl67x3ppK9s41ye4mRPOiUUac86JSjzpi4O3aHojH6jz_5i8DDCHi1NnLbBdfGX__t-wVIDH4l</recordid><startdate>201202</startdate><enddate>201202</enddate><creator>Sishi, Balindiwe J N</creator><creator>Bester, Dirk J</creator><creator>Wergeland, Anita</creator><creator>Loos, Benjamin</creator><creator>Jonassen, Anne K</creator><creator>van Rooyen, Jacques</creator><creator>Engelbrecht, Anna-Mart</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201202</creationdate><title>Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart</title><author>Sishi, Balindiwe J N ; Bester, Dirk J ; Wergeland, Anita ; Loos, Benjamin ; Jonassen, Anne K ; van Rooyen, Jacques ; Engelbrecht, Anna-Mart</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-4d7566c35d929852a3d7d3130276b45d7376a0a1fbfa90b6961898c2d4899eed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Antibiotics, Antineoplastic - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis Regulatory Proteins - biosynthesis</topic><topic>Beclin-1</topic><topic>Caspase 3 - metabolism</topic><topic>Daunorubicin - pharmacology</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Male</topic><topic>Microtubule-Associated Proteins - biosynthesis</topic><topic>Muscle Proteins - metabolism</topic><topic>Myocardium - enzymology</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Proteasome Endopeptidase Complex - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Signal Transduction</topic><topic>SKP Cullin F-Box Protein Ligases - metabolism</topic><topic>Tripartite Motif Proteins</topic><topic>Ubiquitin - metabolism</topic><topic>Ubiquitin-Protein Ligases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sishi, Balindiwe J N</creatorcontrib><creatorcontrib>Bester, Dirk J</creatorcontrib><creatorcontrib>Wergeland, Anita</creatorcontrib><creatorcontrib>Loos, Benjamin</creatorcontrib><creatorcontrib>Jonassen, Anne K</creatorcontrib><creatorcontrib>van Rooyen, Jacques</creatorcontrib><creatorcontrib>Engelbrecht, Anna-Mart</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sishi, Balindiwe J N</au><au>Bester, Dirk J</au><au>Wergeland, Anita</au><au>Loos, Benjamin</au><au>Jonassen, Anne K</au><au>van Rooyen, Jacques</au><au>Engelbrecht, Anna-Mart</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart</atitle><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle><addtitle>Exp Biol Med (Maywood)</addtitle><date>2012-02</date><risdate>2012</risdate><volume>237</volume><issue>2</issue><spage>219</spage><epage>226</epage><pages>219-226</pages><issn>1535-3702</issn><eissn>1535-3699</eissn><abstract>Daunorubicin (DNR) and doxorubicin (DOX) are two of the most effective anthracycline drugs known for the treatment of systemic neoplasms and solid tumors. However, their clinical use is hampered due to profound cardiotoxicity. The mechanism by which DNR injures the heart remains to be fully elucidated. Recent reports have indicated that DOX activates ubiquitin proteasome-mediated degradation of specific transcription factors; however, no reports exist on the effect of DNR on the E3 ubiquitin ligases, MURF-1 (muscle ring finger 1) and MAFbx (muscle atrophy F-box). The aim of this study was to investigate the effect of DNR treatment on the protein and organelle degradation systems in the heart and to elucidate some of the signalling mechanisms involved. Adult rats were divided into two groups where one group received six intraperitoneal injections of 2 mg/kg DNR on alternate days and the other group received saline injections as control. Hearts were excised and perfused on a working heart system the day after the last injection and freeze-clamped for biochemical analysis. DNR treatment significantly attenuated cardiac function and increased apoptosis in the heart. DNR-induced cardiac cytotoxicity was associated with upregulation of the E3 ligases, MURF-1 and MAFbx and also caused significant increases in two markers of autophagy, beclin-1 and LC3. These changes observed in the heart were also associated with attenuation of the phosphoinositide 3-kinase/Akt signalling pathway.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>22328594</pmid><doi>10.1258/ebm.2011.011106</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1535-3702 |
| ispartof | Experimental biology and medicine (Maywood, N.J.), 2012-02, Vol.237 (2), p.219-226 |
| issn | 1535-3702 1535-3699 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_923189505 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Animals Antibiotics, Antineoplastic - pharmacology Apoptosis Apoptosis Regulatory Proteins - biosynthesis Beclin-1 Caspase 3 - metabolism Daunorubicin - pharmacology Gene Expression Regulation, Enzymologic Male Microtubule-Associated Proteins - biosynthesis Muscle Proteins - metabolism Myocardium - enzymology Phosphatidylinositol 3-Kinases - metabolism Proteasome Endopeptidase Complex - metabolism Rats Rats, Wistar Signal Transduction SKP Cullin F-Box Protein Ligases - metabolism Tripartite Motif Proteins Ubiquitin - metabolism Ubiquitin-Protein Ligases - metabolism |
| title | Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T15%3A43%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Daunorubicin%20therapy%20is%20associated%20with%20upregulation%20of%20E3%20ubiquitin%20ligases%20in%20the%20heart&rft.jtitle=Experimental%20biology%20and%20medicine%20(Maywood,%20N.J.)&rft.au=Sishi,%20Balindiwe%20J%20N&rft.date=2012-02&rft.volume=237&rft.issue=2&rft.spage=219&rft.epage=226&rft.pages=219-226&rft.issn=1535-3702&rft.eissn=1535-3699&rft_id=info:doi/10.1258/ebm.2011.011106&rft_dat=%3Cproquest_cross%3E923189505%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=923189505&rft_id=info:pmid/22328594&rft_sage_id=10.1258_ebm.2011.011106&rfr_iscdi=true |